Diazepam (CAS 439-14-5) Anxiolytic Pharmaceutical API

Diazepam (CAS 439-14-5) is a classic benzodiazepine anxiolytic API, renowned for its versatile sedative, anxiolytic, anticonvulsant, and muscle relaxant properties. Its well-characterized molecular structure binds to central nervous system GABA receptors, enhancing inhibitory neurotransmission to calm excessive neuronal activity—effectively alleviating anxiety, inducing sedation, and preventing seizures. This high-purity pharmaceutical raw material complies with global pharmacopoeial standards, ensuring consistent potency and stability for reliable formulation.

Widely applied in pharmaceutical development, it serves as a core ingredient for medications treating generalized anxiety disorder, panic attacks, insomnia, and seizure disorders. It is also valued for managing muscle spasms and facilitating preoperative sedation. With a proven clinical track record and favorable tolerability profile, it addresses diverse unmet medical needs in psychiatric and neurological care. Choose this trusted anxiolytic API to develop high-quality formulations that deliver targeted relief and improve patients’ mental and physical well-being.